Enfusion Inc (ENFN)
9.79
-0.09
(-0.91%)
USD |
NYSE |
Nov 15, 16:00
9.80
+0.01
(+0.10%)
After-Hours: 20:00
Enfusion Research and Development Expense (TTM): 25.55M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 25.55M |
| June 30, 2024 | 23.64M |
| March 31, 2024 | 22.01M |
| December 31, 2023 | 19.89M |
| September 30, 2023 | 18.61M |
| June 30, 2023 | 17.53M |
| March 31, 2023 | 16.79M |
| Date | Value |
|---|---|
| December 31, 2022 | 17.16M |
| September 30, 2022 | 158.94M |
| June 30, 2022 | 157.68M |
| March 31, 2022 | 156.00M |
| December 31, 2021 | 153.40M |
| September 30, 2021 | 8.64M |
| June 30, 2021 | 7.682M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
7.682M
Minimum
Jun 2021
158.94M
Maximum
Sep 2022
57.40M
Average
20.95M
Median
Research and Development Expense (TTM) Benchmarks
| F5 Inc | 490.12M |
| Cognizant Technology Solutions Corp | -- |
| Castellum Inc | -- |
| BM Technologies Inc | -- |
| Marti Technologies Inc | 2.112M |